• Profile
Close

Pre-emptive incision-site infiltration with ropivacaine plus dexamethasone for postoperative pain after supratentorial craniotomy: A prospective randomized controlled trial

Journal of Pain Research Apr 21, 2021

Zhao C, Wang S, Pan Y, et al. - Pain on the incision site is prevented by incision-site infiltration with local anesthetics, however, pain relief is limited to the first few postoperative hours. Studies have described better postoperative pain relief with using dexamethasone as an adjuvant to local infiltration; however, this has not been studied in craniotomy patients yet. Researchers conducted a prospective, single-center, blinded, randomized, controlled trial including patients aged between 18 and 64 years, ASA physical status of I–II, scheduled for elective supratentorial tumor craniotomy under general anesthesia. Eligible participants were randomized (1:1) to either the dexamethasone group who received incision-site infiltration of 0.5% ropivacaine plus 0.033% dexamethasone (N = 70) or the control group who received 0.5% ropivacaine alone (N = 70). Outcomes revealed reduction in nearly 27% of opioids consumption and the postoperative pain scores within 72 hours after craniotomy in correlation with adding dexamethasone to pre-emptive incision-site infiltration with the local anesthetic.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay